Some of the most well-known Janssen products include diarrhoea treatment, Immodium (loperamide), antipsychotic ... the first operating companies in China and Egypt. During the 1990s, Ethicon's ...

Cytokinetics finds a new partner in Greater China for its potential blockbuster drug — it could be one of a handful of ...

Eli Lilly (LLY) stock in focus as China approves its Alzheimer's treatment Kisunla (donanemab). Read more here.

As Cytokinetics’ aficamten awaits approval decisions from regulators in the U.S. and China, Sanofi has picked up China rights ...

China's medical regulator has approved Eli Lilly's treatment for early Alzheimer's, providing patients with another option ...

loperamide and antidepressants. However, data that support the effectiveness of these treatments for patients with multiple IBS features are limited, and some evidence suggests these agents may ...

Apollomics Inc., a late-stage clinical biopharmaceutical company, said its leukemia drug failed to pass trials in China, a ...

Following in the footsteps of several Big Pharma companies, another ALK inhibitor has made its entry into the U.S. The new ...

China expanded its visa-free transit policy to allow citizens from 54 countries, including the U.S., to visit for up to 10 days without a visa. Travelers must be traveling from China to a third ...

Survey sparks concerns over lack of vigilance among young Taiwanese towards Chinese threats A recent Taiwanese survey reveals alarmingly low support among young people for regulating pro-China ...

Merck & Co. snagged a potential drug in the burgeoning market for obesity medications in a deal worth as much as $2 billion.

(This Dec. 17 story has been corrected to say that the EU regulator reversed its July decision in November to recommend ...